Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Colorectal Neoplasms 1422Pancreatic Neoplasms 847Carcinoma, Hepatocellular 736Stomach Neoplasms 639Colonic Neoplasms 441Rectal Neoplasms 400Esophageal Neoplasms 395Carcinoma, Non-Small-Cell Lung 328Breast Neoplasms 328Neoplasms 300Liver Neoplasms 280Cholangiocarcinoma 242Ovarian Neoplasms 240Lung Neoplasms 238Neoplasm Metastasis 237Gastrointestinal Neoplasms 216Melanoma 184Prostatic Neoplasms 162Esophageal Squamous Cell Carcinoma 160Biliary Tract Neoplasms 160Endometrial Neoplasms 141Squamous Cell Carcinoma of Head and Neck 128Uterine Cervical Neoplasms 127Carcinoma, Renal Cell 113Head and Neck Neoplasms 112Sarcoma 100Urinary Bladder Neoplasms 95Adenocarcinoma Of Esophagus 89Triple Negative Breast Neoplasms 84Anus Neoplasms 83

Interventions

dehydroftorafur 1atezolizumab 1Specimen Handling 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
DNA Repair-Deficiency Disorders × Gastrointestinal × 1 year × Clear all
NCT02912559 2026-06-01

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

National Cancer Institute (NCI)

Phase 3 Active not recruiting
712 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Repair-Deficiency Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡